Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹3,445 Cr₹-828 Cr₹-265 Cr₹625 Cr₹1,109 Cr

What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS is ₹3,445 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹3,445 Cr
Mar2025₹-828 Cr
Mar2024₹-265 Cr
Mar2023₹625 Cr
Mar2022₹1,109 Cr

How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹3,445 Cr
Positive
Mar2025 ₹-828 Cr
Negative
Mar2024 ₹-265 Cr
Negative
Mar2023 ₹625 Cr
-43.59
Mar2022 ₹1,109 Cr -

Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹69,308.3 Cr 6.5% 8.6% 25.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,994.0 Cr -0% -4.5% 15.9% Stock Analytics
DIVIS LABORATORIES ₹240,249.0 Cr 5.9% 16.1% 49.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,135.0 Cr 3% 3% 34% Stock Analytics
CIPLA ₹114,708.0 Cr -0.4% -3.6% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.9 Cr NA 2.8% -7.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

6.5%

8.6%

25.7%

SENSEX

-0.8%

0.2%

-6%


You may also like the below Video Courses